Evidence map›Paper›PMID 19190539›Full record

ArticlePediatric research2009

Brain-derived neurotrophic factor in infants <32 weeks gestational age: correlation with antenatal factors and postnatal outcomes.

Rakesh Rao, Charles B Mashburn, Jingnan Mao, Nitin Wadhwa, George M Smith, Nirmala S Desai

Open access · bronzeAbstract read
In one paragraph

Article in Pediatric research, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 51 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Retinopathy of prematurity: risk stratification by gestational age.Journal of perinatology : official journal of the California Perinatal Association · 2023
    Article
  11. Systemic Cytokines in Retinopathy of Prematurity.Journal of personalized medicine · 2023
    Review
  12. Article
  13. Brain, behavior, & immunity - health · 2021
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Observational
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Rakesh RaoDepartment of Pediatrics, Washington University of St. Louis, St. Louis, Missouri 63110, USA. Rao_R@kids.wustl.edu
Charles B Mashburn
Jingnan Mao
Nitin Wadhwa
George M Smith
Nirmala S Desai
University of Kentucky · USWashington University in St. Louis · USRegional Medical Center · US

Funding

BIORESORBABLE MICROFILAMENTS FOR NERVOUS SYSTEM REPAIRR01NS040592 · NINDS · UNIVERSITY OF KENTUCKY · PI SMITH, GEORGE M · 2000 to 2009
$2.7M
NINDS NIH HHS R01 NS040592
6 · The paper itself

Abstract

Neurotrophins (NTs) play important roles in brain growth and development. Cord blood (CB) brain-derived neurotrophic factor (BDNF) concentrations increase with gestational age but data regarding postnatal changes are limited. We measured BDNF concentrations after birth in 33 preterm infants <32-wk gestation. Serum was collected at birth (CB), at day 2, between day 6 and 10 (D6), at day 30 (D30), and at day 60 (D60). BDNF concentrations fell on D2 (p = 0.03), recovered by D6 (p = 0.10), and continued to rise thereafter at D30 (p = 0.06) and D60 (p = 0.01) compared with CB. CB BDNF concentrations positively correlated with duration of rupture of membranes (r = 0.43, p = 0.04). Antenatal steroids (ANS, p = 0.02), postnatal steroids (PNS, p = 0.04), and retinopathy of prematurity (ROP, p = 0.02) were identified as significant factors in multivariate analyses. The median (25-75th interquartile range) CB BDNF concentrations were higher in infants who received a complete course ANS compared with those who received a partial course [1461 (553-2064) versus 281 (171-536) pg/mL, p = 0.04]. BDNF concentrations negatively correlated with the use of PNS at D30 (r = -0.53, p = 0.002) and at D60 (r = -0.55, p = 0.009). PNS use was associated with reduced concentrations of BDNF at D30 [733 (101-1983) versus 2224 (1677- 4400) pg/mL, p = 0.004] and at D60 [1149 (288-2270) versus 2560 (1337-5166) pg/mL, p = 0.01]. BDNF concentrations on D60 in infants who developed ROP (n = 16) were lower than those who did not develop ROP (n = 7) [1417 (553-2540) versus 3593 (2620-7433) pg/mL, respectively, p = 0.005]. Our data suggests that BDNF concentrations rise beyond the first week of age. BDNF concentrations correlate with factors that influence neurodevelopment outcomes.

Indexed as

Child DevelopmentInfant, PrematureAge FactorsBirth WeightBrainBrain-Derived Neurotrophic FactorBronchopulmonary DysplasiaCerebral HemorrhageDrug Administration ScheduleEnterocolitis, NecrotizingFemaleFetal BloodGestational AgeHumansInfant, NewbornMaleBrain-Derived Neurotrophic FactorSteroids

Identifiers

PMID19190539
PMCPMC2735819
OpenAlexW2066411152

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.